| Medical and Health Sciences | Lifetime | 239 | US 130 | 99.99 |
| Rheumatology | Lifetime | 8 | US 3 | 99.95 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 78 | US 46 | 99.78 |
| Immunology | Lifetime | 145 | US 84 | 99.69 |
| Epidemiology | Lifetime | 829 | US 421 | 98.89 |
| Pathology and Forensic Medicine | Lifetime | 405 | US 188 | 98.36 |
| Medical Genetics | Lifetime | 322 | US 165 | 97.26 |
| Hematology | Lifetime | 621 | US 317 | 95.19 |
| Nephrology | Lifetime | 747 | US 344 | 89.20 |
| Hepatology | Lifetime | 721 | US 265 | 87.63 |
| Rehabilitation | Lifetime | 815 | US 309 | 80.21 |
| Rheumatology | 2021-2025 | 22 | US 7 | 99.54 |
| Immunology | 2021-2025 | 527 | US 190 | 85.10 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 775 | US 266 | 81.84 |
| Pathology and Forensic Medicine | 2021-2025 | 455 | US 149 | 80.49 |
| Systemic Lupus Erythematosus Research | Lifetime | 5 | US 2 | 99.95 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 11 | US 9 | 99.95 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 11 | US 7 | 99.84 |
| Systemic Sclerosis and Related Diseases | Lifetime | 8 | US 3 | 99.79 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 6 | US 4 | 99.66 |
| T-cell and B-cell Immunology | Lifetime | 49 | US 35 | 99.88 |
| Salivary Gland Disorders and Functions | Lifetime | 19 | US 6 | 99.43 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 108 | US 63 | 99.64 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 79 | US 39 | 99.48 |
| Renal Diseases and Glomerulopathies | Lifetime | 76 | US 38 | 99.42 |
| Diabetes and associated disorders | Lifetime | 122 | US 64 | 99.26 |
| Liver Diseases and Immunity | Lifetime | 55 | US 22 | 99.30 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 108 | US 53 | 99.16 |
| Immune Cell Function and Interaction | Lifetime | 648 | US 347 | 99.16 |
| Platelet Disorders and Treatments | Lifetime | 175 | US 68 | 98.67 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 202 | US 59 | 99.12 |
| Galectins and Cancer Biology | Lifetime | 170 | US 69 | 97.99 |
| Protein Tyrosine Phosphatases | Lifetime | 64 | US 33 | 97.54 |
| Lymphoma Diagnosis and Treatment | Lifetime | 585 | US 271 | 98.54 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 227 | US 74 | 98.48 |
| Hermeneutics and Narrative Identity | Lifetime | 437 | US 137 | 92.58 |
| Peripheral Neuropathies and Disorders | Lifetime | 273 | US 87 | 97.82 |
| Heat shock proteins research | Lifetime | 313 | US 137 | 96.40 |
| Skin Diseases and Diabetes | Lifetime | 107 | US 47 | 96.75 |
| Urticaria and Related Conditions | Lifetime | 370 | US 119 | 96.86 |
| Celiac Disease Research and Management | Lifetime | 268 | US 67 | 96.34 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 531 | US 233 | 96.74 |
| Eosinophilic Disorders and Syndromes | Lifetime | 672 | US 281 | 95.48 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 104 | US 42 | 94.86 |
| Blood disorders and treatments | Lifetime | 544 | US 221 | 94.35 |
| Vasculitis and related conditions | Lifetime | 579 | US 158 | 95.11 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 276 | US 104 | 94.89 |
| thermodynamics and calorimetric analyses | Lifetime | 348 | US 142 | 93.41 |
| Neurogenetic and Muscular Disorders Research | Lifetime | 988 | US 362 | 92.79 |
| Dermatological and COVID-19 studies | Lifetime | 199 | US 51 | 91.00 |
| Spondyloarthritis Studies and Treatments | Lifetime | 927 | US 157 | 92.08 |
| Medical and Biological Ozone Research | Lifetime | 954 | US 261 | 78.60 |
| Paraoxonase enzyme and polymorphisms | Lifetime | 515 | US 106 | 75.80 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 13 | US 7 | 99.56 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 54 | US 22 | 98.61 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 44 | US 12 | 97.08 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 328 | US 147 | 96.50 |
| T-cell and B-cell Immunology | 2021-2025 | 416 | US 173 | 90.82 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 157 | US 45 | 92.00 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 467 | US 134 | 91.95 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 346 | US 73 | 91.17 |
| Platelet Disorders and Treatments | 2021-2025 | 372 | US 79 | 89.63 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 429 | US 80 | 89.43 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 981 | US 134 | 86.91 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 390 | US 79 | 78.09 |
| Liver Diseases and Immunity | 2021-2025 | 549 | US 132 | 83.98 |
| Salivary Gland Disorders and Functions | 2021-2025 | 632 | US 87 | 75.09 |
| Skin Diseases and Diabetes | 2021-2025 | 179 | US 46 | 71.08 |
| Drug-Induced Ocular Toxicity | 2021-2025 | 200 | US 75 | 46.21 |
